CrossrefInfokarte
Metabolic Reprogramming and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Mechanisms and Therapeutic Strategies
Anticancer Research · 2026-07 · 46 (7) · 3599-3608
DOI: 10.21873/anticanres.18226 ↗Abstract
Kein Abstract verfügbar.
EUVIMED